@article{b0e81d58bad34363a135d169347435d8,
title = "Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement",
author = "Richard Sullivan and Grant Lewison and Julie Torode and Kingham, {Peter T.} and Murray Brennan and Shulman, {Lawrence N.} and Mark Lawler and Ajay Aggarwal and Julie Gralow",
note = "Funding Information: The research funding organisation landscape across the UK and USA shows notable differences. In the UK, 33% of cancer research publications acknowledge funding from four government agencies compared with 88% in the USA (particularly the US National Cancer Institute and National Institutes of Health; appendix pp 3–5 ). Charities and foundations account for 33% of cancer research funding in the UK, but only 8% in the USA. UK cancer researchers also acknowledge more than 8% of their funding from EU sources. For UK and USA collaborative papers only, the National Cancer Institute and other National Institutes of Health organisations dominated, along with the American Cancer Society, whereas the UK funding for such collaborations was split between Cancer Research UK, the National Institute of Health Research (the funding group of the UK Government's Department of Health and Social Care), the Medical Research Council (UK Research and Innovation for the UK Government), and the independent charity Wellcome Trust, along with substantial acknowledgment of EU funding ( appendix p 6 ). ",
year = "2022",
month = apr,
doi = "10.1016/S1470-2045(22)00079-1",
language = "English",
volume = "23",
pages = "460--462",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "4",
}
